Rheumatoid Arthritis

Researchers examined the association between inflammation-reducing medications and dementia risk in patients with rheumatoid arthritis.

Researchers examined the association between inflammation-reducing medications and dementia risk in patients with rheumatoid arthritis.

This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...

Making a diagnosis of psoriatic arthritis can be challenging, because as many as 10% of patients with psoriatic arthritis may have a positive test result for rheumatoid factor or anticitrullinated peptide...

In a recent study, researchers examined an appropriate cutoff value for identifying a rheumatoid arthritis flare.

In a recent study, researchers measured the impact of oral glucocorticoids on rheumatoid arthritis–associated pain over time.

During a patient-profiling, data-driven study, researchers reveal 5 phenotypes associated with patients with rheumatoid arthritis.

Researchers stress importance of diet in improving rheumatoid arthritis symptoms.

Does the combination of oral glucocorticoids and proton pump inhibitors heighten the risk of osteoporotic fractures among patients with rheumatoid arthritis? A new study sheds light on the issue.